Evaluation of the MicroScan Urinary Combo Panel and API 20E system for identification of glucose-nonfermenting gram-negative bacilli isolated from clinical veterinary materials.
AUTOR(ES)
Mathewson, J J
RESUMO
Many isolates of glucose-nonfermenting gram-negative bacilli (NFB) cultured from clinical veterinary specimens are not identified because of the large number of identification tests required. We evaluated two commercial identification systems to determine if they could accurately identify NFB isolated from animals. Of 182 strains of NFB, the MicroScan Urinary Combo Panel (MicroScan, Inc., Campbell, Calif.) correctly identified 72%, and the API 20E system (Analytab Products, Plainview, N.Y.) correctly identified 74%. Of the 118 strains of the three most common species of NFB isolated from animals, the MicroScan Urinary Combo Panel identified 86% correctly, and the API 20E system identified 92% correctly. The use of either of these systems could improve the accuracy of identification of NFB from clinical veterinary materials.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=272588Documentos Relacionados
- Glucose-nonfermenting Gram-negative bacilli associated with clinical veterinary specimens.
- Ability of the MicroScan Rapid Gram-Negative ID Type 3 Panel To Identify Nonenteric Glucose-Fermenting and Nonfermenting Gram-Negative Bacilli
- Critical evaluation of the AutoMicrobic system gram-negative identification card for identification of glucose-nonfermenting gram-negative rods.
- Evaluation of the AutoMicrobic system for identification of glucose-nonfermenting gram-negative rods.
- Multicenter evaluation of the MicroScan Rapid Gram-Negative Identification Type 3 Panel.
